List of works - Francisco J Ramos

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

scientific article

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

scientific article published on 11 November 2017

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.

scientific article published on 06 March 2009

Aurora kinase family: a new target for anticancer drug.

scientific article published on June 2008

Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study.

scientific article published on 25 November 2009

Cetuximab and Chemotherapy for Patients with Unresectable CRC Liver Metastasis: Are We Changing the Natural Course of the Disease?

scientific article published on 30 November 2007

Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.

scientific article published on July 2009

Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.

scientific article published on 10 March 2008

Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.

scientific article

K-Ras mutation status as a predictive biomarker in metastatic colorectal cancer

scientific article published on 01 April 2008

Lack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine Tumors

scientific article published on 01 August 2005

Monoclonal antibodies in the treatment of advanced colorectal cancer.

scientific article published on 5 November 2007

New approaches and targets in advanced colorectal cancer.

scientific article published in September 2009

New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.

scientific article published on July 2007

Pharmacogenomic and pharmacoproteomic studies of cetuximab in metastatic colorectal cancer: biomarker analysis of a phase I dose-escalation study.

scientific article published on 25 January 2010

Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors.

scientific article

Right-left or midgut-hindgut?

scientific article published on 21 August 2017

Severe serotonin syndrome induced by mirtazapine monotherapy.

scientific article

The role of salvage treatment in advanced colorectal cancer.

scientific article

Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.

scientific article published on December 2008

Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer.

scientific article published on September 2008

List of works by Francisco J Ramos

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.

Aurora kinase family: a new target for anticancer drug.

Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study.

Cetuximab and Chemotherapy for Patients with Unresectable CRC Liver Metastasis: Are We Changing the Natural Course of the Disease?

Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.

Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.

Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.

K-Ras mutation status as a predictive biomarker in metastatic colorectal cancer

Lack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine Tumors

Monoclonal antibodies in the treatment of advanced colorectal cancer.

New approaches and targets in advanced colorectal cancer.

New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.

Pharmacogenomic and pharmacoproteomic studies of cetuximab in metastatic colorectal cancer: biomarker analysis of a phase I dose-escalation study.

Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors.

Right-left or midgut-hindgut?

Severe serotonin syndrome induced by mirtazapine monotherapy.

The role of salvage treatment in advanced colorectal cancer.

Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.

Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer.